Molecular surveillance for drug-resistant Plasmodiumfalciparum malaria in Malawi.

Abstract

We assessed the presence of point mutations associated with resistance to chloroquine (CQ) and sulphadoxine-pyrimethamine (SP) in 178 Plasmodiumfalciparum infections from three geographically distinct sites in Malawi. We confirm that CQ-resistance mutations are now rare in Malawi, being detectable at very low frequencies (2-4%) in infections from two of the three study sites. We also show that over 90% of infections from each of the three study sites carry a set of three dihydrofolate reductase (dhfr) and two dihydropteroate synthase (dhps) mutations strongly associated with SP treatment failure. In this short communication, we present these molecular data and discuss their implications for Malawi's first-line antimalarial treatment policy.

• Authors: Standwell Nkhoma, Malcolm Molyneux, Stephen Ward
• Journal: Acta tropica (Acta Trop) Vol. 102 Issue 2 Pg. 138-42 (May 2007) ISSN: 0001-706X [Print] Netherlands
• PMID: 17544355 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antimalarials
• DNA, Protozoan
• Drug Combinations
• Membrane Transport Proteins
• PfCRT protein, Plasmodium falciparum
• Protozoan Proteins
• fanasil, pyrimethamine drug combination
• Sulfadoxine
• Chloroquine
• Tetrahydrofolate Dehydrogenase
• Dihydropteroate Synthase
• Pyrimethamine

Topics

• Animals
• Antimalarials (pharmacology)
• Chloroquine (pharmacology)
• DNA, Protozoan (chemistry, genetics)
• Dihydropteroate Synthase (chemistry, genetics)
• Drug Combinations
• Drug Resistance (genetics)
• Humans
• Malaria, Falciparum (drug therapy, parasitology)
• Malawi
• Membrane Transport Proteins (chemistry, genetics)
• Plasmodium falciparum (enzymology, genetics, growth & development)
• Point Mutation
• Protozoan Proteins (chemistry, genetics)
• Pyrimethamine (pharmacology)
• Sequence Analysis, DNA
• Sulfadoxine (pharmacology)
• Tetrahydrofolate Dehydrogenase (chemistry, genetics)